Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Stockholm - Delayed Quote SEK

Medicover AB (publ) (MCOV-B.ST)

Compare
205.50
+4.50
+(2.24%)
At close: 5:29:55 PM GMT+2
Loading Chart for MCOV-B.ST
  • Previous Close 201.00
  • Open 202.00
  • Bid 205.00 x --
  • Ask 205.50 x --
  • Day's Range 201.00 - 206.00
  • 52 Week Range 129.20 - 219.50
  • Volume 30,240
  • Avg. Volume 63,719
  • Market Cap (intraday) 30.854B
  • Beta (5Y Monthly) 1.52
  • PE Ratio (TTM) 164.40
  • EPS (TTM) 1.25
  • Earnings Date Apr 29, 2025
  • Forward Dividend & Yield 1.69 (0.84%)
  • Ex-Dividend Date Apr 30, 2025
  • 1y Target Est 222.11

Medicover AB (publ) provides healthcare and diagnostic services in Poland, India, Romania, Sweden, and internationally. Its Healthcare services includes service outpatient and inpatient care; dental services; other services, including non-medical related services, such as sports memberships, benefit cards, and optics, as well as wellness services; hospital care; and preventive care. The company's Diagnostic Services offers laboratory tests in all major clinical pathology areas, ranging from routine to advanced tests and from prevention to monitoring of treatments. Its also comprise various tests, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry and immunochemistry, blood group diagnostics/transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology and immunochemistry, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology. It serves corporate, individuals, and public payers. Medicover AB (publ) was founded in 1995 and is headquartered in Stockholm, Sweden.

www.medicover.com

47,256

Full Time Employees

December 31

Fiscal Year Ends

Recent News: MCOV-B.ST

View More

Performance Overview: MCOV-B.ST

Trailing total returns as of 4/14/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .

YTD Return

MCOV-B.ST
7.03%
OMX Stockholm 30 Index (^OMX)
5.82%

1-Year Return

MCOV-B.ST
51.44%
OMX Stockholm 30 Index (^OMX)
6.71%

3-Year Return

MCOV-B.ST
8.91%
OMX Stockholm 30 Index (^OMX)
11.75%

5-Year Return

MCOV-B.ST
120.57%
OMX Stockholm 30 Index (^OMX)
52.28%

Compare To: MCOV-B.ST

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: MCOV-B.ST

View More

Valuation Measures

Annual
As of 4/11/2025
  • Market Cap

    30.18B

  • Enterprise Value

    42.98B

  • Trailing P/E

    162.09

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.30

  • Price/Book (mrq)

    5.86

  • Enterprise Value/Revenue

    1.86

  • Enterprise Value/EBITDA

    14.01

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.80%

  • Return on Assets (ttm)

    2.24%

  • Return on Equity (ttm)

    2.87%

  • Revenue (ttm)

    2.09B

  • Net Income Avi to Common (ttm)

    16.7M

  • Diluted EPS (ttm)

    1.25

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    82.8M

  • Total Debt/Equity (mrq)

    253.20%

  • Levered Free Cash Flow (ttm)

    89M

Research Analysis: MCOV-B.ST

View More

Company Insights: MCOV-B.ST

Research Reports: MCOV-B.ST

View More

People Also Watch